Märkte
| Wertpapier | Kurs | % ▲ | Buy | Sell | Kursziel | Potential |
|---|---|---|---|---|---|---|
| Egalet Corp |
-
- |
- | 0 | 0 | - | - |
| Achaogen Inc |
-
- |
- | 0 | 0 | - | - |
| ContraFect Corp. |
0,059 €
08.06.23 |
- | 0 | 0 | - | - |
| TapImmune Inc |
-
- |
- | 0 | 0 | - | - |
| First Wave BioPharma Inc. |
3,95 €
15.12.23 |
- | 2 | 0 | 23,48 € | 494,84 % |
| Synergy Pharmaceuticals |
-
- |
- | 0 | 0 | - | - |
| Takara Bio Inc. |
6,55 €
30.07.24 |
- | 0 | 1 | - | - |
| Soligenix Inc. |
5,85 €
09.02.24 |
- | 0 | 0 | - | - |
| Aceto Corp. |
-
- |
- | 0 | 0 | - | - |
| Lipocine Inc. |
3,67 €
09.02.24 |
- | 1 | 15 | 4,50 € | 22,55 % |
| Conatus Pharmaceuticals Inc. |
0,53 €
13.08.20 |
- | 0 | 0 | - | - |
| VIVUS Inc |
0,41 €
02.10.20 |
- | 0 | 0 | - | - |
| Advaxis Inc. |
0,059 €
23.09.22 |
- | 0 | 16 | - | - |
| Sienna Biopharmaceuticals |
0,010 €
10.03.20 |
- | 0 | 0 | - | - |
| Sophiris Bio Inc. |
0,20 €
05.08.20 |
- | 0 | 0 | - | - |
| Benitec Biopharma Ltd ADR |
0,55 €
18.11.19 |
- | 0 | 0 | - | - |
| Immune Pharmaceuticals Inc |
0,001 €
27.07.22 |
-75,00 % | 0 | 0 | - | - |
| Histogenics Corp. |
0,14 €
30.09.19 |
-30,94 % | 0 | 0 | - | - |
| Heat Biologics Inc. |
0,069 €
14.06.24 |
-24,86 % | 0 | 0 | - | - |
| Nuvectra Corp |
0,10 €
13.12.19 |
-23,08 % | 0 | 0 | - | - |
| Evoke Pharma Inc. |
0,37 €
30.07.24 |
-19,74 % | 0 | 24 | - | - |
| IntelliPharmaCeutics International Inc. |
0,045 €
06.03.24 |
-13,59 % | 0 | 0 | - | - |
| Aradigm Corp. New |
0,097 €
18.07.19 |
-12,15 % | 0 | 0 | - | - |
| Celldex Therapeutics |
35,60 €
30.07.24 |
-11,28 % | 18 | 1 | 62,02 € | 74,20 % |
| Tetraphase Pharmaceuticals |
0,22 €
26.09.19 |
-10,67 % | 0 | 0 | - | - |
| Aptevo Therapeutics Inc. |
0,12 €
05.03.24 |
-10,29 % | 0 | 0 | - | - |
| Purple Biotech Ltd. ADR |
0,34 €
19.07.24 |
-8,09 % | 6 | 0 | 9,21 € | 2608,38 % |
| SELLAS Life Sciences Group Inc |
1,07 €
31.07.24 |
-7,99 % | 0 | 1 | - | - |
| Lysogene SA |
0,21 €
06.01.23 |
-7,76 % | 0 | 1 | 0,000 € | -100,00 % |
| Genomic Vision S.A. |
0,001 €
03.11.23 |
-7,14 % | 0 | 0 | - | - |